NFATC2 and graft versus host disease: Based on the assumption of the presence of functional redundancy among the RUNX family members [29], we hypothesize targeting whole‐RUNX family by Chb‐M’ can down‐regulate NFATC2 and pro‐inflammatory cytokine genes of T cells, and reduce GVHD severity.